Business · 05/10/1995Updated: 10/18/2026 · 1 min read
FDA Announces Public Meeting to Discuss Prescription Drug Product Labeling
Summary
The FDA is hosting a public meeting to gather feedback on its proposed revisions to prescription drug product labeling, with the goal of improving communication between healthcare professionals and the labeling itself.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →